209,066 Shares in Viemed Healthcare, Inc. $VMD Acquired by Rice Hall James & Associates LLC

Rice Hall James & Associates LLC bought a new position in shares of Viemed Healthcare, Inc. (NASDAQ:VMD) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund bought 209,066 shares of the company’s stock, valued at approximately $2,383,000. Rice Hall James & Associates LLC owned about 0.55% of Viemed Healthcare at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the business. North Star Investment Management Corp. bought a new stake in shares of Viemed Healthcare in the first quarter worth $921,000. Arrowstreet Capital Limited Partnership raised its position in Viemed Healthcare by 101.9% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 711,186 shares of the company’s stock worth $6,550,000 after purchasing an additional 358,863 shares during the last quarter. GSA Capital Partners LLP bought a new position in Viemed Healthcare during the 2nd quarter worth $1,455,000. Lazard Asset Management LLC lifted its holdings in Viemed Healthcare by 117.6% during the 1st quarter. Lazard Asset Management LLC now owns 215,938 shares of the company’s stock worth $1,989,000 after buying an additional 116,700 shares during the period. Finally, Hillsdale Investment Management Inc. acquired a new position in Viemed Healthcare during the 1st quarter worth about $1,834,000. Institutional investors own 74.24% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on VMD shares. Freedom Capital cut Viemed Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 5th. Weiss Ratings raised Viemed Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, August 3rd. Finally, Wall Street Zen cut Viemed Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday. One equities research analyst has rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold”.

Viemed Healthcare Stock Performance

Shares of VMD stock opened at $9.12 on Wednesday. The firm has a 50 day moving average of $11.07 and a 200-day moving average of $9.85. The company has a market cap of $347.38 million, a price-to-earnings ratio of 25.33 and a beta of 1.10. The company has a quick ratio of 1.02, a current ratio of 1.13 and a debt-to-equity ratio of 0.04. Viemed Healthcare, Inc. has a 52 week low of $6.05 and a 52 week high of $12.61.

Viemed Healthcare (NASDAQ:VMD) last announced its quarterly earnings data on Monday, August 3rd. The company reported $0.07 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.05). Viemed Healthcare had a net margin of 4.81% and a return on equity of 10.16%. The company had revenue of $78.10 million for the quarter, compared to analyst estimates of $78.00 million. On average, equities analysts forecast that Viemed Healthcare, Inc. will post 0.42 earnings per share for the current year.

Insider Activity at Viemed Healthcare

In other news, Director Timothy Smokoff sold 20,000 shares of the business’s stock in a transaction that occurred on Wednesday, June 24th. The stock was sold at an average price of $11.50, for a total value of $230,000.00. Following the transaction, the director owned 75,518 shares in the company, valued at $868,457. The trade was a 20.94% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider William Frazier sold 10,000 shares of the business’s stock in a transaction on Thursday, June 25th. The stock was sold at an average price of $11.72, for a total value of $117,200.00. Following the completion of the transaction, the insider directly owned 73,214 shares in the company, valued at approximately $858,068.08. This represents a 12.02% decrease in their position. The disclosure for this sale is available in the SEC filing. 20.60% of the stock is owned by insiders.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.